-
Kenya's economy faces climate change risks: World Bank
-
Gaza ceasefire a 'deadly illusion': UNICEF
-
European robotics start-ups go up against Chinese heavyweights
-
'Alter-Ego': An Italian hospital's little robot carer
-
Indonesia to capture last-known wild Bornean rhino for IVF
-
No vaccine, conflict, mistrust: Ebola's return to DR Congo
-
AI museum brings sights, sounds and smells of the rainforest
-
New Zealand minister defends fishers after two orcas killed in net
-
Football 'ambassador' and fan favorite: a duck becomes a star in Mexico
-
Fossils challenge assumptions on how animals adapted to land
-
US stocks resume upward climb as dollar advances again after Fed outlook
-
Al-Qaeda-linked jihadists attack Niger airport, 11 soldiers killed
-
AI-generated videos use Down syndrome to make sales
-
Ghana pushes for concrete slavery reparations
-
Europe risks 'total irrelevance' without sovereign tech: Cohere chief
-
AI-generated videos wield Down syndrome to make sales
-
Suspected jihadists stage deadly new attack on Niger airport
-
Man dies, trains and classes disrupted as heatwave hits France
-
Oil tankers pass Hormuz Strait after war deal: tracker
-
Swiss central bank holds interest rates, with eye on currency risks
-
S.African sentenced in 'world's largest' rhino trafficking case
-
Bank of England follows Fed in holding interest rate
-
German chemical company to cut 3,200 jobs as crisis worsens
-
Range raises $8.3M Series A to unify treasury, risk and compliance across stablecoins and fiat
-
Innovations on show at Paris Vivatech fest
-
Bird flu kills 13,000 seal pups on remote Australian island
-
New wave of anti-LGBTQ laws sweeps Africa
-
Drastic restrictions on public transport take effect in Cuba
-
Cuba approves economic reforms to boost private sector, investment: state TV
-
Robots pour cocktails and run marathons, but still can't multitask
-
Birthright citizenship helps spark US World Cup run
-
Castro gives crucial backing to Cuba reforms
-
Driving the World's Leading Supply Chains: 9 OMP Customers Named to The 2026 Gartner Top 25
-
Qantas to launch non-stop Sydney-London flights in October 2027
-
US Fed chair Warsh vows reforms as central bank signals rate hikes on horizon
-
US Federal Reserve holds rates steady, raises inflation expectations
-
Brest boss Roy dies aged 58 from cancer
-
Military salutes and K-pop madness shake up Colombia campaigning
-
Recovery of ship traffic in Hormuz limited, but signs emerge
-
England's World Cup opener puts Spanish resort on beer alert
-
Nations allege 'attacks' on science at key climate talks
-
Plague was killing hunter-gatherers 5,500 years ago: study
-
Prince Harry and family to visit UK in July: media
-
What happens when the Strait of Hormuz re-opens?
-
US retail sales beat expectations in May as energy costs stay high
-
Spain logs third-warmest year on record in 2025
-
'Heartbreaking': Afghan govt staff abandon smartphones
-
Groundbreaking US astronaut Christina Koch wins top Spanish award
-
BBC eyes compulsory redundancies in cost-cutting drive
-
Sovereignty fears dog AI enthusiasm at France's Vivatech
Musk's Neuralink eyes more test subjects for its brain tech
Elon Musk on Wednesday said his Neuralink startup is "moving on" to a second test patient as its tech for linking brains and computers improves.
Musk and members of the Neuralink team fielded questions during an update streamed on X, formerly Twitter, discussing where it is on the path to making its brain implants commonplace.
"We're only just moving now to our second Neuralink patient," Musk said. "But we hope to have, if things go well, high single digits this year."
Musk's neurotechnology company in January installed a brain implant in Noland Arbaugh, which the billionaire head of Tesla and X touted as a success.
Arbaugh was left paralyzed from the shoulders down by a diving accident eight years ago.
Since the implant operation, he has told of playing chess and the video game "Civilization," as well as taking Japanese and French lessons by controlling a computer screen cursor with his brain.
Musk and members of the Neuralink team detailed fixing an issue that saw Arbaugh's ability to move a computer cursor with his mind greatly reduced.
Neuralink's technology works through a device about the size of five stacked coins that is placed inside the human brain by a robotic surgeon.
Threads connecting the implant to Arbaugh's brain had "retracted," becoming less effective at picking up signals.
Threads will be implanted deeper in the brain and at varying depths, with ramped-up precision to maximize effectiveness, according to the Neuralink team.
Musk promised "it's only going to get better from here."
One goal is to escalate the bandwidth of the link between the brain and computer, allowing more data to move faster, according to Musk.
"Quite important for human-AI symbiosis is just being able to communicate at a speed AI can follow," Musk said of brains being connected to computers with artificial intelligence.
Musk envisions Neuralink implants going beyond restoring sight to the blind to giving people infrared or ultraviolet vision or letting them share concepts with others telepathically.
"We want to give people superpowers," Musk said. "Not just that we're restoring your prior functionality, but that you actually have functionality far greater than a normal human."
Musk spoke of developing an automated process in which Neuralink's surgery robot could quickly install custom implants in people seeking "upgrades."
"It's very sort of 'Cyberpunk' or 'Deus Ex,' if you play those games," Musk said of the idea.
"An exciting possibility long term also is to take parts of the Optimus humanoid robot and combine that with a Neuralink - you could have basically cybernetic superpowers," he said.
Musk cofounded Neuralink in 2016.
The ambition is to supercharge human capabilities, treat neurological disorders like ALS or Parkinson's, and maybe one day achieve a symbiotic relationship between humans and AI.
Musk is not alone in trying to make advances in the field, which is officially known as brain-machine or brain-computer interface research.
P.Schmidt--CPN